Dr. Bogenschutz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
462 1st Avenue
New York, NY 10016Phone+1 646-501-4026
Summary
- Dr. Michael Bogenschutz is a psychiatrist in New York, NY.
Education & Training
Cambridge Health AllianceResidency, Psychiatry, 1990 - 1994
Harvard Medical SchoolClass of 1990, MD, Cum Laude
Certifications & Licensure
NY State Medical License 2015 - 2026
NM State Medical License 1994 - 2016- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD Start of enrollment: 2019 Oct 16
Roles: Contact
- Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD Start of enrollment: 2024 Jul 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsA clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs.Michael P Bogenschutz
Addiction. 2025-02-01 - Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clini...Broc A Pagni, Richard J Zeifman, Sarah E Mennenga, Brennan M Carrithers, Noam Goldway
The American Journal of Psychiatry. 2025-01-01 - Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.Jennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, Scott Shannon, Michael Bogenschutz
Nature Medicine. 2024-11-01
Press Mentions
“Shifts in Personality” Could Be Key to Psilocybin Helping SUD PatientsJanuary 9th, 2025- Psychedelic Therapy Shows Promise in Alleviating Mental Health Issues for Cancer Patients and AddictsJanuary 2nd, 2025
- Psychedelic Drug Therapy May Address Mental Health Concerns in People with Cancer & AddictionJanuary 2nd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
